medigraphic.com

2012, Number 2

Next >>

Cuba y Salud 2012; 7 (2)

The performance of the National Cervicouterine Cancer Control Program in a policlinic in Havana, Cuba

Ordás GA, García MAJ, Duany JN

Language: Spanish
References: 18
Page: 2-7
PDF size: 670.12 Kb.


ABSTRACT

Objetive: To describe the performance of the Cervicouterine Cancer Prevention Program in the “5 de Septiembre” Policlinic.
Method: A transverse descriptive study that was carried out during the period of 2001-2005. The sample consisted of all cytologies performed during the described period. The variables studied were: age, type of cytology, quality of the exam, recovery and cytological diagnosis. The performance of the Program was determined by the type of cytology and the age group; age variables and the quality of the exam were compared through the Ji-squared test, and the Pearson correlation was used to analyze the behavior of the recovery rates. Significant differences of p‹0.05 were considered.
Results: 7117 cytologies were performed, 469 new cases and 6652 re-exams (93.5%). The performance of the Program for the 25-59 year old age group varied between 79.1% and 92.4%, and 89.4% and 97.9% for the 60+ age group. A normal cytology was the main result found and no cases of invasive carcinomas were informed. The recovery rates of the cytologies by unusable samples significantly increased in the investigation period.
Conclusions: Some irregularities were observed at the given policlinic in the carrying out of the Cervicouterine Cancer Prevention Program, essentially given by the non- compliance of re-exams. The rate of unusable samples was low, linked to an increase in the rate of recovery during the study period. The prevalence of intracervical neoplasia cases in their distinct stages was low and no cases of invasive carcinomas were reported.


REFERENCES

  1. Causes of death. World Health Statistics annual 1991. Ginebra, OMS, 1991. Disponible en: http://www.who.int/whosis/ whostat/EN_WHS10_Full.pdf [acceso: Febrero 2012]

  2. Programa Nacional de diagnóstico precoz del cáncer cervico-uterino. Ministerio de Salud Pública. República de Cuba. 1984:1

  3. Guía Clínica Cáncer cérvico-uterino 2. 1st Ed. Santiago, Chile: MINSAL 2005. Disponible en: http://www.redsalud.gov.cl/ archivos/guiasges/CancerCervicouterino.pdf [acceso: Febrero 2012]

  4. Asociación Internacional de Registros de Cáncer & IARC. 2002.

  5. Diagnóstico y Tratamiento. Cáncer Cervico-Uterino, Comisión Nacional de Cáncer Cervico-uterino. Ministerio de Salud. Chile, Abril 2004.

  6. Booser DJ, Hortobagyi GN. Anthracycline antibiotics in cancer therapy. Focus on drug resistance. Drugs 1994;47: 223-258.

  7. Dirección Nacional de Estadística, Anuario Estadístico. La Habana: MINSAP. 2009. http://bvs.sld.cu/anuario/tablas/ ANUARIOCU1.1-2244.htm. [acceso: Febrero 2012].

  8. Boote DJ. Phase I study of etoposide with SDZ PSC 833 as a modulator of multidrug resistance in patients with cancer. J Clin Oncol 1996;14:610-8.

  9. Reeder S, Martin L, Konoak D. Valoración y control en la promoción de la salud de la mujer en: Enfermería materno infantil. 17 Edición. Editora Interamericana McGraw-Hill. México. 2000:1275.

  10. American Collage of Obstetrician and Gynecologists. Report of task force on routine cancer screening. Washington. 1989:1275.

  11. Cuba. MINSAP. Programa Nacional de Diagnóstico Precoz del Cáncer Cervicouterino. La Habana: Editorial Ciencias Médicas; 2001:9.

  12. American Cancer Society: Guidelines for the cancer-related checkups: Recommendations and rationale. 1980:195-230.

  13. OMS. Informe sobre la Salud en el Mundo. Reducir los riesgos y promover una vida sana. Mensaje de la Directora General Dra. Gro Harlem Brundtland. Ginebra. Octubre de 2002. Disponible en: http://www.who.int/entity/whr/2002/Overview%20spain. pdf [acceso: Febrero 2012].

  14. Dunám Cruz LK, Cala Calviño L, Infante Tabío NI, Hernández Lin T. Factores de riesgo ginecoobstétricos para el cáncer cervicouterino en la atención primaria de salud. 2011;15(5). Disponible en: http://www.scielo.sld.cu/scielo.php?script=sci_ issuetoc&pid=1029...pt [acceso: Febrero 2012].

  15. Stephen J. McPhee. William F. Ganong. 5ta edicion. Editorial El Manual Moderno, S.A, de C.U, México, D.F., 2007. Disponible en: http://www.medicomoderno.blogspot.com/.../links-actualizados-fisiopatologia.ht... [acceso: Febrero 2012].

  16. Andújar M, Pavcóvich M, Sánchez MA, Torres A, Arias MD, De Lera JM, et al. Prevalencia de la infección cervical por el virus de papiloma humano en la población femenina de Gran Canaria. Estudio poblacional. Resultados preliminares. 7mo. Congreso Virtual Hispanoamericano de Anatomía Patológica y I Congreso de Preparaciones Virtuales por Internet, 1-31 octubre, 2005. Disponible en: htpp://www.conganat.org/7congreso/PDF/558.pdf, [acceso: Febrero 2012].

  17. National Cancer Institute at the National Institutes of Health. Cervical cancer screening. Description of evidence. Disponible en: http://cancer.gov./cancertopics/pdq/screening/cervical/HealthProfessional/pag2 [Last Modified: 02/06/2012; acceso: Febrero 2012].

  18. Smith T, Davidson N, Schapira D et al. American Society of Clinical Oncology 1998 Update of recommended breast cancer surveillance guidelines J Clin Oncol. 1999;17(3):1080-1082.




2020     |     www.medigraphic.com